iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Dr Reddys Laboratories Ltd Option Chain

1,285.8
(-0.95%)
Sep 25, 2025|10:29:57 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,000₹0.05 0%6,8750%
--1,040₹0.2 0%13,1250%
--1,060₹0.05 0%18,7500%
--1,080₹0.2 0%1,03,7500%
5,6250%₹204.75 0%1,100₹0.05 -50%4,99,3750%
--1,120₹0.05 0%4,21,875-0.29%
18,7500%₹115.6 0%1,140₹0.45 125%1,05,000-4.54%
5,0000%₹132.95 0%1,160₹0.7 180%1,72,5001.84%
18,1250%₹120 0%1,180₹0.65 44.44%1,21,875-2.01%
62,5000%₹104 0%1,200₹0.8 45.45%4,79,375-1.66%
66,8750%₹71.95 -0.48%1,220₹1.25 25%4,11,250-0.45%
1,11,875-4.27%₹45 -16.82%1,240₹1.65 32%3,91,2500.16%
2,50,000-2.20%₹29 -13.69%1,260₹3.2 56.09%5,76,2504.89%
4,65,625-3.49%₹11.85 -27.07%1,280₹6.5 28.71%5,46,250-4.48%
40,93,125-0.04%₹3.05 -39%1,300₹16.4 21.48%11,53,750-12.13%
21,35,000-2.59%₹1 -41.17%1,320₹36.2 19.86%2,13,750-10.93%
8,71,250-5.42%₹0.4 -50%1,340₹56.85 16.02%74,375-6.29%
5,11,8750.24%₹0.3 -33.33%1,360₹74.35 6.82%31,2500%
2,26,250-1.63%₹0.15 -50%1,380₹87.85 0%20,0000%
5,40,000-4.31%₹0.1 -33.33%1,400₹108.8 0%26,2500%
1,10,000-1.12%₹0.05 -75%1,420--
45,0000%₹0.2 0%1,440--
34,3750%₹0.1 -60%1,480₹178.8 0%1,2500%

Dr Reddys Labs: Related NEWS

US FDA Issues Form 483 With Five Observations at Dr Reddy’s Biologics Facility

The inspection, conducted between September 4 and September 12, 2025, was a pre-approval review.

15 Sep 2025|11:10 AM
Read More
Top Stocks for Today - 15th September 2025

Here are some of the stocks that may see significant price movement today: Apollo Hospitals, GMR Airports, RailTel Corporation, etc.

15 Sep 2025|07:44 AM
Read More
Dr Reddy’s Infuses ₹565 Cr into Russian Arm

The capital was infused via cash and will be used to support DRL Russia’s working capital requirements.

28 Jul 2025|12:22 PM
Read More
Dr Reddy’s Laboratories inks pact with Alvotech; stock gains ~3%

As per the terms agreement, Alvotech and Dr Reddy’s will jointly develop and manufacture the biosimilar candidate and share costs and responsibilities.

5 Jun 2025|11:00 AM
Read More
Dr. Reddy’s Receives Two USFDA Observations for New York API Manufacturing Plant

Issuance of a Form 483 occurs when an investigator(s) has observed any conditions that in their judgment may constitute violations of the FD&C Act and related Acts.

18 May 2025|07:17 PM
Read More
Dr Reddy’s Q4 Profit Jumps 22% to ₹1,594 Crore

The board has recommended a final dividend of ₹8 per equity share for FY 2024–25

12 May 2025|01:00 PM
Read More
Top Stocks for Today - 12th May 2025

Here are some of the stocks that may see significant price movement today: Adani Power, Dr Reddy's, and Bank of India, etc.

12 May 2025|09:32 AM
Read More
Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

5 Mar 2025|11:05 AM
Read More
Top Stocks for - 27th February 2025

Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.

26 Feb 2025|09:22 PM
Read More
Dr Reddy’s Hyderabad API Unit Gets USFDA VAI Classification

Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore. 

25 Feb 2025|08:42 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.